{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:25:02Z","timestamp":1792808702492,"version":"4.5.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy of the adrenal cortex. This study characterizes a single-institution cohort of children treated for ACC, and explores the relationship between clinical outcomes of ACC and germline <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutation status. We performed a retrospective chart review of 23 consecutive pediatric patients with ACC treated at The Hospital for Sick Children, Toronto, Canada, between 1977 and 2017. Clinical, biochemical, radiologic, pathologic, and genetic data were collected for each patient. ACC diagnosis followed a bimodal age distribution of 0 to 6 (n=17) and 12+ (n=6) years, with a female:male ratio of 3.6:1. Ten of 20 patients tested for germline <jats:italic toggle=\"yes\">TP53<\/jats:italic> status carried a pathogenic (9) or likely pathogenic (1) variant, including all but 1 male patient. Only 3 patients died of ACC-related causes, each 5 months post-diagnosis. When treated with resection and combination chemotherapy, carriers of germline <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations may respond more favorably than their wild-type counterparts. In addition, the survival of patients reported in our cohort with high-stage ACC was appreciably greater than previously described (100.0% for stage II, 50.0% for stage III, and 42.9% for stage IV), favoring aggressive intervention in these patient populations.<\/jats:p>","DOI":"10.1097\/mph.0000000000001982","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T19:09:59Z","timestamp":1603998599000},"page":"e635-e641","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Outcomes of Children With Adrenocortical Carcinoma in the Context of Germline TP53 Status"],"prefix":"10.1097","volume":"43","author":[{"given":"Connor T.A.","family":"Brenna","sequence":"first","affiliation":[{"name":"Medicine"},{"name":"Program in Genetics and Genome Biology, The Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orli","family":"Michaeli","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Toronto"},{"name":"Hematology\/Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Toronto"},{"name":"Endocrinology, The Hospital for Sick Children Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malkin","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Toronto"},{"name":"Program in Genetics and Genome Biology, The Hospital for Sick Children"},{"name":"Hematology\/Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","article-title":"The Weiss system for evaluating adrenocortical neoplasms: 25 years later","volume":"40","author":"Lau","year":"2009","journal-title":"Hum Pathol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cancergen.2012.02.009","article-title":"The molecular basis of adrenocortical cancer","volume":"205","author":"Lehmann","year":"2012","journal-title":"Cancer Genet"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/his.12283","article-title":"Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers","volume":"64","author":"Wang","year":"2014","journal-title":"Histopathology"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis","volume":"351","author":"Wasserman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(05)70113-4","article-title":"Adrenal cancer","volume":"29","author":"Stratakis","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2, suppl","key":"R8-20250804","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C","article-title":"Cancer incidence, survival, and mortality for children younger than age 15 years","volume":"58","author":"Young","year":"1986","journal-title":"Cancer"},{"key":"R9-20250804","first-page":"305","article-title":"International variations in the incidence of childhood carcinomas","volume":"3","author":"Stiller","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-20250804","first-page":"1017","article-title":"Adrenocortical carcinoma in adults and children: a population-based outcomes study involving 1,623 patients from the surveillance, epidemiology, and end result (SEER) database (1973-2012)","volume":"1","author":"Mahendraraj","year":"2016","journal-title":"Gen Surg"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"key":"R12-20250804","first-page":"1317","article-title":"Adrenocortical tumors","volume":"82","author":"Latronico","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0022-3468(93)90341-H","article-title":"Adrenocortical carcinoma in children: clinical aspects and prognosis","volume":"28","author":"Sabbaga","year":"1993","journal-title":"J Pediatr Surg"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0094-0143(21)01829-2","article-title":"Adrenocortical carcinoma in children","volume":"16","author":"Chudler","year":"1989","journal-title":"Urol Clin North Am"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/jpsu.2001.22280","article-title":"Adrenocortical tumors in children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/JCO.1990.8.1.67","article-title":"Adrenocortical carcinoma in children: a study of 40 cases","volume":"8","author":"Ribeiro","year":"1990","journal-title":"J Clin Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2013.02.017","article-title":"Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","article-title":"Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center","volume":"169","author":"Ayala-Ramirez","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpedsurg.2015.10.039","article-title":"Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB)","volume":"51","author":"Gulack","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ajcp\/101.5.625","article-title":"Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors","volume":"101","author":"Bugg","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2350\/08-06-0489.1","article-title":"Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?","volume":"12","author":"Dehner","year":"2009","journal-title":"Pediatr Dev Pathol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20250804","first-page":"2018","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"2693","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1200\/JCO.2016.34.15_suppl.10515","article-title":"Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: results of the Children\u2019s Oncology Group ARAR0332 protocol","volume":"34","author":"Rodriguez-Galindo","year":"2016","journal-title":"J Clin Oncol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2007-0243","article-title":"Molecular markers and the pathogenesis of adrenocortical cancer","volume":"13","author":"Soon","year":"2008","journal-title":"Oncologist"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.20318","article-title":"Biology, clinical characteristics, and management of adrenocortical tumors in children","volume":"45","author":"Rodriguez-Galindo","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Massimo","year":"2007","journal-title":"New Engl J Med"},{"key":"R32-20250804","first-page":"2234","article-title":"Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer","volume":"85","author":"Terzolo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2015.00023","article-title":"Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors","volume":"6","author":"Lalli","year":"2015","journal-title":"Front Endocrinol"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-Fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.22559","article-title":"Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome","volume":"35","author":"Kamihara","year":"2014","journal-title":"Hum Mutat"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting mutant p53 for efficient cancer therapy","volume":"18","author":"Bykov","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1158\/0008-5472.CAN-05-4580","article-title":"Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma","volume":"66","author":"West","year":"2006","journal-title":"Cancer Res"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R45-20250804","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10689-017-0028-4","article-title":"p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers","volume":"17","author":"Macedo","year":"2018","journal-title":"Fam Cancer"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children\u2019s Oncology Group Study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"R47-20250804","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/86.22.1707","article-title":"High frequency of germline p53 mutations in childhood adrenocortical cancer","volume":"86","author":"Wagner","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R48-20250804","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"},{"key":"R49-20250804","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol"},{"key":"R50-20250804","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer screening recommendations for individuals with Li-Fraumeni syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R51-20250804","first-page":"2027","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-20250804","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-911X(199703)28:3<175::AID-MPO3>3.0.CO;2-G","article-title":"Clinical characteristics of small functioning adrenocortical tumors in children","volume":"28","author":"Michalkiewicz","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R53-20250804","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"New Engl J Med"},{"key":"R54-20250804","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1897-4287-4-2-81","article-title":"Childhood adrenocortical tumours: a review","volume":"4","author":"Marques-Pereira","year":"2006","journal-title":"Hered Cancer Clin Pract"},{"key":"R55-20250804","doi-asserted-by":"crossref","first-page":"E1284","DOI":"10.1210\/jc.2012-1184","article-title":"SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes","volume":"97","author":"Letouz\u00e9","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20250804","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1200\/JCO.2017.74.2460","article-title":"Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: a St Jude Adrenocortical Tumor Registry and Children\u2019s Oncology Group Study","volume":"35","author":"Pinto","year":"2017","journal-title":"J Clin Oncol"},{"key":"R57-20250804","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R58-20250804","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ju.0000180645.89054.fd","article-title":"The impact of tumor stage on prognosis in children with adrenocortical carcinoma","volume":"174","author":"Tucci","year":"2005","journal-title":"J Urol"},{"key":"R59-20250804","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"R60-20250804","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"R61-20250804","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0015-0282(16)47961-6","article-title":"The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women","volume":"42","author":"Hoffman","year":"1984","journal-title":"Fertil Steril"},{"key":"R62-20250804","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/gme.0b013e3182698f80","article-title":"Dehydroepiandrosterone sulfate (DHEAS) levels reflect endogenous LH production and response to human chorionic gonadotropin (hCG) challenge in the older female macaque (Macaca fascicularis)","volume":"20","author":"Moran","year":"2013","journal-title":"Menopause"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:11:02Z","timestamp":1754338262000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001982","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"2020-07-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}